RE: GenOMICC18 Jul 2021 13:07
Hi Cobalt,
Is there a reason why we are not on the list of studies? I imagine the simplest answer would be we are on a list of studies, just not the one you looked at. Our recent study relates to a grant awarded to Sareum through the Innovate UK Sustainable Innovation Fund for projects that address and mitigate the health, social, cultural and environmental impacts of the Covid-19 outbreak.
AGILE is not the ultimate goal, it is only one possibility. The 1/7/21 RNS states (with regard to funding & progress), "...this could include the UK government's AGILE clinical development platform, which was established to fund Phase 1 trials and fast-track the development of potentially ground-breaking Covid-19 treatments. These activities are expected to run in parallel with the broader SDC-1801 development plan targeting autoimmune diseases. We look forward to providing updates on our progress as we reach key milestones in the development of SDC-1801.
What I'd infer from all of this is we have options. As Tarantino might say, 'we all just need to chill the **** out and be like little Fonzies'.
Regards,
Hotblack.